These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2687984)

  • 1. Cell-mediated immune response in psoriasis and psoriatic arthritis.
    Ventura M; Colizzi M; Ottolenghi A; Polignano A; Sinisi DA; Rantuccio F; Antonaci S; Bonomo L
    Recenti Prog Med; 1989 Sep; 80(9):449-54. PubMed ID: 2687984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of phagocyte functions, inflammatory lymphokine activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis.
    Antonaci S; Jirillo E; Polignano A; Ventura MT; Sabato R; Bonomo L
    Cytobios; 1991; 67(270-271):135-44. PubMed ID: 1800021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T and B cell function in psoriasis and psoriatic arthropathy.
    Zarrabeitia MT; Fariñas MC; Rodríguez-Valverde V; Riancho JA; Llaca HF
    Allergol Immunopathol (Madr); 1989; 17(3):155-9. PubMed ID: 2816658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular and humoral immune phenomena in psoriatic arthritis].
    Neumüller J; Senautka G; Dunky A; Neumann H; Mayer F; Much T; Eberl R; Partsch G
    Wien Klin Wochenschr; 1983 Jun; 95(12):416-22. PubMed ID: 6604367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoresponsiveness in hemophilia: lymphocyte- and phagocyte-mediated functions.
    Antonaci S; Jirillo E; Stasi D; De Mitrio V; La Via MF; Bonomo L
    Diagn Clin Immunol; 1988; 5(6):318-25. PubMed ID: 3219781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune regulation in psoriasis and psoriatic arthritis--recent developments.
    Hueber AJ; McInnes IB
    Immunol Lett; 2007 Dec; 114(2):59-65. PubMed ID: 17928070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zinc therapy on neutrophil chemotaxis in psoriasis.
    Leibovici V; Statter M; Weinrauch L; Tzfoni E; Matzner Y
    Isr J Med Sci; 1990 Jun; 26(6):306-9. PubMed ID: 2380030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis.
    Sakkas LI; Loqueman N; Bird H; Vaughan RW; Welsh KI; Panayi GS
    J Rheumatol; 1990 Nov; 17(11):1487-90. PubMed ID: 2273489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
    Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
    Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of CD8+ T lymphocytes in psoriatic arthritis.
    Costello P; Bresnihan B; O'Farrelly C; FitzGerald O
    J Rheumatol; 1999 May; 26(5):1117-24. PubMed ID: 10332977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis.
    Daoussis D; Antonopoulos I; Andonopoulos AP; Liossis SN
    Rheumatology (Oxford); 2007 Feb; 46(2):227-31. PubMed ID: 16861707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide in psoriatic arthritis.
    Kaltwasser JP
    Autoimmun Rev; 2007 Sep; 6(8):511-4. PubMed ID: 17854740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris.
    Menssen A; Trommler P; Vollmer S; Schendel D; Albert E; Gürtler L; Riethmüller G; Prinz JC
    J Immunol; 1995 Oct; 155(8):4078-83. PubMed ID: 7561119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity in psoriatic arthritis.
    Espinoza LR; Gaylord SW; Vasey FB; Osterland CK
    J Rheumatol; 1980; 7(2):218-24. PubMed ID: 6966333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
    Krueger G; Callis K
    Arch Dermatol; 2004 Feb; 140(2):218-25. PubMed ID: 14967799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.